相关实验视频

Updated: Jun 25, 2025

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Published on: June 9, 2016

一种新的贝叶斯生成方法,用于从已发表的研究中估计瘤动态

Arya Pourzanjani¹, Saurabh Modi¹, Jamie Connarn¹

¹Clinical Pharmacology Modeling & Simulation (CPMS) Department, Amgen Inc., South San Francisco, California, USA.

CPT: pharmacometrics & systems pharmacology

|May 23, 2024

概括

这项研究引入了贝叶斯模型,用已发表的总结数据来估计瘤生长抑制 (TGI) 参数,如无进展生存率 (PFS) 和客观响应率 (ORR),克服了稀疏纵向瘤测量的局限性.

科学领域:

药物指标 (Pharmacometrics) 是一个指标.
数学瘤学数学瘤学
生物统计学生物统计学

背景情况:

瘤生长抑制 (TGI) 模型对于理解癌症治疗很有价值,但需要纵向瘤数据,这往往是不可用的.
传统的暴露-反应模型依赖于临床终点,而TGI模型提供了更动态的瘤变化的视图.
发表的数据通常包括总结统计数据,如从瘤测量中得出的无进展生存率 (PFS) 和客观响应率 (ORR).

研究的目的:

开发一个贝叶斯生成模型,仅使用总结级PFS和ORR数据估计TGI模型参数.
在无法获得详细的纵向瘤测量时,以实现TGI建模.
提供一种方法来量化治疗效果和瘤动态中的人口变异性.

主要方法:

建立了贝叶斯生成模型,将潜在的瘤动态与总结PFS和ORR数据联系起来.
该模型是使用公开可用的多项已发表的癌症治疗研究总结数据来拟合的.
学习的TGI模型参数被聚合并用于in silico模拟.

主要成果:

开发的模型成功地从总结数据中学习了TGI参数,证明了它的可行性.
参数化模型有效地描述了瘤动态和量化治疗效应.
这种方法允许计算各种研究群体之间的差异.

结论:

这种新的贝叶斯方法使得使用易于获得的总结统计数据 (PFS,ORR) 进行TGI建模,解决数据的局限性.
该模型有助于更深入地了解瘤动态和瘤研究中的治疗疗效.
该方法的实用性通过应用到已发表的研究和in silico试验模拟来验证.

更多相关视频

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Published on: July 6, 2013

相关概念视频

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...